spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

Right arrow Help viewing high resolution images
Right arrow Return to article
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.


Figure 2


Fig. 2. Nek6 phosphorylates Eg5 in vitro at a conserved site that is phosphorylated during mitosis. (A) Recombinant GST-HsEg5 or His6-XlEg5 were phosphorylated by FLAG-Nek6. The insets show 32P incorporation with time (upper gel, left to right with no kinase in rightmost lane) and a Coomassie-blue stain of the substrate (lower gel). (B) Myelin basic protein (MBP, positive control), maltose-binding protein (MalBP), or MalBP fusion proteins containing the Eg5 segments indicated were incubated with [{gamma}-32P]ATP/Mg2+ and either FLAG-Nek6 (odd-numbered lanes) or pre-activated FLAG-Nercc1 (even-numbered lanes) for 30 minutes followed by SDS-PAGE. The upper panels show Coomassie-blue stains of the gels and the lower panels the corresponding autoradiographs. White arrowheads indicate Nercc1 and black arrowheads indicate Nek6. Asterisks indicate the location of MBP (lanes 3 and 4) or MalBP fusion proteins (7-12). The left gel is 12% acrylamide, the right gel 7.5%; Nek6 is run off the latter. (C) HsEg5, human Eg5; MmEg5, mouse Eg5; XlEg5, X. laevis Eg5; KLP61F, D. melanogaster KLP61F; bmk-1, C. elegans BMK-1; BimC, A. nidulans BimC; KIP1/Cin8p, S. cerevisiae KIP1/Cin8p; Cut7, S. pombe Cut7. Identical and conserved residues are shaded; regions conserved around the C-terminal CDK1 site (BimC box) and Nek6 site (LXXS*) are boxed. (D) Using normal IgG (NIgG) and anti-HsEg5 antibodies, immunoprecipitates were prepared from extracts of 32P-labelled U2OS cells growing exponentially (Exp) or incubated overnight in 0.25 mM nocodazole (M), and subjected to SDS-PAGE; a PhosphoImage of the gel is shown. (E) Left, two-dimensional tryptic phosphopeptide map of endogenous 32P-Eg5 immunoprecipitated from 32P-labelled mitotic U2OS cells, visualized by PhosphorImager. Right, phosphopeptide map of purified recombinant 32P-GST-Eg5 phosphorylated in vitro by immunoprecipitated mitotic CDK1. The gray arrows mark phosphopeptides attributed to CDK1; the black arrow indicates a 32P-peptide evident in digests of mitotic Eg5 that is not present in digests of CDK1-phosphorylated 32P-Eg5. (F) Top left, two-dimensional phosphopeptide map of endogenous Eg5 immunoprecipitated from 32P-labelled mitotic U2OS cells; right (top and bottom), two-dimensional maps of recombinant GST-Eg5 wild type (wt; top right) and GST-Eg5[Ser1033Ala] (bottom right) phosphorylated in vitro by FLAG-Nek6; note in the lower right map the absence of the most anodally migrating 32P-peptide seen in the upper right map, which encompasses Ser1033-P. Bottom left, a mixture of comparable amounts of the digests of mitotic 32P-Eg5 and FLAG-Nek6-phosphorylated 32P-Eg5. The arrow marks the phosphopeptide common to the two digests, which contains Ser1033. In the digests of mitotic 32P-Eg5 (E, left; F, upper left), this spot contains ~3% of total 32P, estimated by PhosphorImager.





Right arrow Return to article